
07/15/2025
WELL is pleased to share a corporate update on its majority-owned subsidiary, Wellstar highlighting continued strength across revenue growth, strategic acquisitions, and AI innovation.
WELLSTAR is ahead of internal expectations, raising its fiscal 2025 guidance to:
➡️ $74M total revenue
➡️ $22M in Adjusted EBITDA
➡️ $62M in total ARR, with an exit ARR of $80M — a 50% increase YoY
The company has also executed three LOIs expected to add:
➡️ $15M in ARR
➡️ $16M in revenue
➡️ $5M+ in Adjusted EBITDA (annualized)
WELLSTAR’s new Nexus AI™ solution is also gaining strong traction. As a pre-qualified vendor for Canada Health Infoway’s AI Scribe Program, eligible primary care providers can now receive a fully-funded Nexus AI license for 12 months.
More details here: https://ow.ly/IYQG50WpT3u